Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.

JNCI cancer spectrum - 2 Mar 2022

Horton Carolyn, Blanco Kirsten, Lo Min-Tzu, Speare Virginia, LaDuca Holly, Dolinsky Jill S, Kurian Allison W

Abstract excerpt

BACKGROUND: With increased adoption of multi-gene panel testing (MGPT) for hereditary cancer, management guidelines now include a wider range of predisposition genes. Yet little is known about whether MGPT results prompt changes to clinicians' risk management recommendations and whether those recommendations adhere to guidelines. METHODS: We assessed cancer risk management recommendations made by clinicians...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Germ Cells

Share to Neoplasms

Share to Risk Management

Source

Open in PubMed Open full text

Identifiers

PMID: 35603838
DOI: 10.1093/jncics/pkac002
PMCID: PMC8904928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.PMID 35603838Read ↗

Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.Semantic proximity Read ↗

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskSemantic proximity Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access.Semantic proximity Read ↗

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read ↗

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsSemantic proximity Read ↗

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.Semantic proximity Read ↗

Risks and Implications of Multiple Actionable Pathogenic Germline Variants Discovered by Panel-Based Cancer Predisposition Testing.Semantic proximity Read ↗

IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.Semantic proximity Read ↗

An analysis of the impact of annual cancer genetic testing guideline updates on a past patient population.Semantic proximity Read ↗

Effects of Cancer Genetic Panel Testing on at-Risk Individuals.Semantic proximity Read ↗

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.